Myxoid Pleomorphic Liposarcoma: A Review and Update

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Myxoid pleomorphic liposarcoma (MPLPS) is a rare adipocytic neoplasm.
• It primarily affects children and young adults, often in the mediastinum.
• MPLPS exhibits aggressive clinical behavior with high metastatic potential.

Purpose of the Study:

• To review the clinicoradiological, histopathological, and molecular features of MPLPS.
• To discuss current management strategies and therapeutic challenges.
• To aid in the differential diagnosis of this rare tumor.

Main Methods:

• Review of existing literature on MPLPS.
• Analysis of clinicoradiological, histological, and immunohistochemical findings.
• Summary of molecular alterations including TP53 mutations and RB1 deletions.

Main Results:

• MPLPS shows a mix of myxoid and pleomorphic liposarcoma components.
• Tumor cells express CD34 and p16, with loss of nuclear RB.
• Key molecular features include TP53 mutations, RB1 deletions, and genome-wide loss of heterozygosity, distinguishing it from other liposarcomas.

Conclusions:

• MPLPS is a distinct entity with aggressive behavior requiring specialized management.
• Surgical resection with negative margins is crucial for localized disease.
• Advanced or metastatic MPLPS presents significant therapeutic challenges.